Category Archives: Medicine Wellness Health

Medicine Wellness Health

New: Funny cartoons assist nuclear medicine physicians

Help for children during nuclear medical examinations

New: Funny cartoons assist nuclear medicine physicians

Sunny & Tim and their team help children through nuclear medical examinations (Source: Dr Ronald van Rheenen, Floris de Jonge)

Nuclear medical examinations can be stressful for patients – particularly for children. But Sunny the Isotope, Tim the Tracer and Rob the Receptor help reduce the strain. These cartoon characters, which have been developed by Ronald van Rheenen, expert of the European Association of Nuclear Medicine (EANM)., The Visual Education Project that gave birth to these characters provides child patients with age-appropriate information on the imaging examination. They make preparation rules easy to understand and lend a touch of fun and adventure to the procedure.
Undergoing a nuclear medical imaging examination can be quite a challenge. Some of these procedures last over an hour. During this time the patient is required to lie still on the imaging bed and avoid any motions as these might render the images being created useless for diagnostic purposes. For the same reason eating is sometimes not allowed prior to the imaging. All this is particularly demanding for children whose examinations make up an estimated 10 % of all nuclear medical examinations. They are also intimidated by the unfamiliar environment with its large nuclear medicine cameras whose detectors are placed very close to the body and somtetimes directly over the patient“s head. Concerns that the examination might be painful add to young patients“ anxiety. The accompanying parents are not always able to cheer up their child as they themselves might be distressed not knowing what to expect and which results the examination will provide.
In order to alleviate such fears and improve diagnostic accuracy through better cooperation of doctors and their young patients Dr Ronald van Rheenen, Nuclear Medicine Physician at the University Medical Hospital in Groningen (Netherlands) initiated the nonprofit Visual Education Project. Its „heoresheroes“ are Sunny the Isotope and Tim the Tracer, cartoon characters who appear in three different stories where they stand for the radioactive and the tracer substance that together form the radiopharmaceutical the patient is injected with. Tim takes Sunny on a journey through the body and guides him to Rob the Receptor who represents the target organ where the radiopharmaceutical accumulates. There Sunny shines his „special lights“ which reperesent the emitted radiation. This enables the „Photo Doctor“ to take pictures of the diseased areas. While this refers to diagnostic procedures one of the story lines also addresses nuclear medical therapy: This time Sunny & Tim are joined by Sam the Demolisherwho destroys the sick-spot. The stories are freely available as animations on YouTube and can be purchased as picture books (for links see below). Dr. van Rheenen, who pursues these educational activities in his free time, cooperates closely with the graphic designer Floris de Jonge. He brought the characters and storylines to life that Dr. van Rheenen had in mind. Meanwhile both have created three other storylines dealing with radiological imaging examinations.
The adventurous stories, straightforwardly told and catchily illustrated, not only help dissolve anxieties but also guide the childrens“ preparation before and their behaviour during examination. But the education material not only aims at very young readers. It might even help adults with low-health-literacy to understand the procedures and purposes of nuclear medicine. „Our decision to convey information in the form of visualized stories is motivated by the fact that most of the textual or verbal information which is provided prior to our examinations or therapy, is not correctly remembered – if at all,“ says Dr. van Rheenen. The project that started off three years ago as a local initiative based in Groningen has already spread its material considerably. The EANM and several European hospitals as well as patient platforms have the animations running on their websites or refer to it. With the support of the EANM the project is now on the verge of developing into a global initiative. Currently, versions in German, Spanish, French and Cantonese are under way and Dr. van Rheenen is dicussing possibilities of further dissemination with different National Nuclear Medicine Societies.
„It is essential to tailor explanations to the childrens“ grasping ability. Introducing the Visual patient education project to pediatric nuclear medicine and explaining the procedure with cartoon characters is a very promising tool to alleviate fears and apprehension and to transform the nuclear medicine study into a fun experience. This improved patient experience leads to improved cooperation resulting in studies of higher technical quality, ultimately leading to improved diagnostic accuracy“, says Dr. Zvi Bar-Sever, Chairman of the EANM pediatric committee.

Presseagentur für Medizinthemen

Kontakt
impressum health & science communication
Frank von Spee
Hohe Brücke 1
20459 Hamburg
040 31786410
vonspee@impressum.de
http://www.impressum.de

Medicine Wellness Health

Heart disease: nuclear imaging improves diagnostic

(Vienna, March 21, 2017) Heart catheterizations for assessing coronary heart disease are often unnecessary and can be replaced with functional cardiac imaging techniques. This is the result of a large-scale study recently conducted in the UK. „Functional cardiac imaging is less risky and less costly while providing accurate and reliable results. It is a good diagnostic starting point that should serve as gatekeeper for angiography,“ says Prof. Riemer H.J.A. Slart, cardiovascular expert of the European Association of Nuclear Medicine (EANM).

Chest pain might be a sign of coronary heart disease (CHD). If patients present with these symptoms it is essential to clarify whether this suspicion can be confirmed or not. Several diagnostic ways are available to detect CHD and determine whether revascularization – the restoration or improvement of the blood flow to the heart – is needed. A classical method is coronary angiography (CAG), an invasive technique that requires the catheterization of the heart. However, over the past decade two functional cardiac imaging techniques that create images of the heart and the coronary vessels have become important alternatives: Myocardial perfusion scintigraphy (MPS) and cardiovascular magnetic resonance (CMR). MPS is a nuclear imaging technique based on gamma-rays emitted by injected radiopharmaceuticals that accumulate in organs while CMR as a subfield of magnetic resonance imaging uses strong magnetic fields that interact with hydrogen atomic nuclei of the body.

MPS as well as CMR enable precise characterizations of the coronary system and allow for the localization of areas in the heart with an insufficient blood supply. They play a key role in diagnosing cardiovascular diseases, establishing prognoses and assessing the efficiency of possible therapies. The success of these imaging methods is even still growing as the underlying technological processes are continuously being improved. Compared to CAG these imaging techniques offer several benefits: They are non-invasive and less risky, they reduce the patients“ strain and help save costs. Despite these advantages, though, CAG is still much too frequently used at an early diagnostic stage in patients with suspected CHD. Too many of these patients undergo cardiac catheterization without obstructive coronary disease being found, a practice that exposes patients to unnecessary risks and creates avoidable costs. This has been shown by the CE-MARC 2 trial, a randomized study recently performed in six hospitals in the UK including 1202 patients with suspected coronary heart disease. Prof. Riemer H.J.A. Slart, cardiovascular expert of the EANM, points to the crucial result of the study: „Employing non-invasive functional cardiac imaging – MPS as well as CMR – results in a significant reduction of unnecessary angiography.“

Guidelines induce too many angiograms
The study divided the 1202 patients into three groups in order to compare three diagnostic strategies for clarification of suspected CHD: The first one used CMR and the second one MPS as a diagnostic starting point. The third strategy followed the guidelines of the British National Institute for Health and Care Excellence (NICE). In this latter group, those patients with a CHD pre-test likelihood of 10%-29% (defined as „low risk“ for CHD based on age, sex, symptoms, and medical history) were referred to cardiac computed tomography (CCT), while patients with a CHD pre-test likelihood of 30% to 60% (intermediate risk) were scheduled for MPS, and those with a high pre-test likelihood of over 60% were sent directly to coronary angiography. In the other two groups angiography was only provided as a possible follow-up examination. The researchers found that within 12 months 42,5 % of the patients belonging to the NICE guidelines group underwent coronary angiography while only 17,7 % of the CMR group and 16,2% of the MPS group did so. But the most important result is that 29% of the heart catheterizations carried out in patients of the NICE guidelines group turned out to be unnecessary but only 7,5% in the CMR group and 7,1% in the MPS group. The rate of clinical complications occurring after the 12 months test period did not differ between the three groups. One additional finding concerns CCT, which the NICE guidelines require for patients with low CHD risk. It turned out that the number of unnecessary angiograms that were performed on the basis of foregoing CCT examinations was significantly higher than that which were based on functional imaging results.

„It has become quite clear that coronary angiography needs to be restricted to cases that really require invasive examination. Functional imaging should be adopted easier and more frequently in the assessment of CHD, even in high risk groups. This is in the patients“ interest as well as for the benefit of the health care systems,“ says Prof. Slart. However, as the EANM expert points out, the new guidelines of the European Society of Cardiology (ESC) – which apply in several European countries – already fulfill these requests in part. While the British NICE guidelines define a CHD pre-test likelihood of 60% as threshold for immediate angiography the ESC guidelines require a pre-test likelihood of 85%. „The ESC guidelines certainly are a step in the right direction,“ says Prof. Slart.

What is nuclear medicine?

Presseagentur für Medizinthemen

Kontakt
impressum health & science communication
Frank von Spee
Hohe Brücke 1
20459 Hamburg
040 31786410
vonspee@impressum.de
http://www.impressum.de

Medicine Wellness Health

HELP JOSELITO! – New Therapies for an Autistic Child

HELP JOSELITO! - New Therapies for an Autistic Child

An autistic boy in Mexico, an overwhelmed family looking for help, a Frenchman with a vision: these are the ingredients of Dr. Jean Weinfeld’s therapy crowdfunding project „HELP JOSELITO!“. Yet its continuation depends on supporters searched on https://www.gofundme.com/help-joselito-an-autistic-child. Joselito’s innovative therapy has already given astonishing results, it can also help other autistic children – but now it needs financial support.

Joselito’s therapy experiment started in late 2014. Dr. Jean Weinfeld developed an extensive and original therapy concept, in which he included a psychologist and a rhythm therapist in Mexico. First, a pragmatic therapy fosters Joselito’s motor and cognitive abilities in everyday life. Second, an aesthetic-sensorial therapy helps Joselito to open up and communicate with the outside world through lyrical stimuli that aim to „surprise“ his senses. Dr. Jean Weinfeld recorded both project and therapy concept in a book written in 4 languages: English, Spanish, French and German. The book and its free e-book version of „HELP JOSELITO! A Health and Therapy Project for a Mexican Autistic Child“ were released in February by GRIN Publishing.

Achievements of the therapy program for autistic children

Joselito (Jose Guillermo Águila Guerrero) suffers under an Autistic Spectrum Disorder. The program designed for him can be yet applied to other persons with a Pervasive Development Disorder. For instance Dr. Jean Weinfeld tried a concept variant with an Asperger child.

The program focuses on creativity and expressivity, to which speech also belongs. Success was first reached by classical speech training. Joselito trains his motor abilities and coordination by a combined movement, rhythm and music therapy, also by dance, drum and piano playing. This enabled him to interact in a playful way with other people and to get along with his life – without stress or constraint. Now, the aesthetic-sensorial part of the therapy concept includes excursions. Numerous pictures and videos document Joselito’s therapy successful results on https://www.facebook.com/Help-Joselito-1722097254768537/

However, without the help of donors Dr. Weinfeld and Joselito’s therapists cannot pursue their work on this concept. Help them to help! https://www.gofundme.com/help-joselito-an-autistic-child

The author and initiator

Dr. Jean Weinfeld, the author and founder of the project „HELP JOSELITO!“, has been working for decades in the field of cross-cultural education. Born in France Dr. Weinfeld now lives in Germany; he already published several specialist books in French, German and Spanish. Dr. Weinfeld travels regularly to Mexico to continue and expand this therapeutic program on the spot together with the therapists. Suggestions and comments related to this program are most welcome.

Der GRIN Verlag publiziert seit 1998 akademische eBooks und Bücher. Wir veröffentlichen alle wissenschaftlichen Arbeiten: Hausarbeiten, Bachelorarbeiten, Masterarbeiten, Dissertationen, Fachbücher uvm.

Kontakt
GRIN Verlag / Open Publishing GmbH
Janine Linke
Nymphenburger Str. 86
80636 München
+49-(0)89-550559-27
presse@grin.com
http://www.grin.com

Medicine Wellness Health

Global Medical Pillows Market 2016 Global Industry Analysis, Market Key Trends, Growth, Shares, Current and Future Players

Global Medical Pillows Market 2016: Report firstly reviews the basic information of the product including its classification, application and manufacturing technology; The report explores world’s top manufacturers and listing their product specifica

MRS Research Group added new research report on Global Medical Pillows Market 2016-2022 includes Market Size, Share, Trends, Growth, Demand, Supply, Application, Segmentation, Opportunity, Market Development, production, capacity utilization, supply, Analysis and Forecast by 2022

Global Medical Pillows Market 2016 Industry, Market Research Report‘ is an in-depth and detailed analysis of the Global Medical Pillows Market 2016. This is a specialized and inclusive analysis of forecast trends, market demands, market size. Furthermore, the report is inclusive of quantitative forecasts of market analysis, company supply, and products. The ‚Global Medical Pillows Market 2016 Industry report assistsa number of companies to understand latest trends, assorted products, and shifting product dynamics.

Global Medical Pillows Market 2016 Segment by Countries, this report splits Global into several key Countries, with sales, revenue, market share of top 5 players in these Countries, from 2012 to 2017 (forecast), like United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa

The report directs and guides through company shares along with sales and distribution with regards to client“s interest. This reporthighlightsthe emerging technologies that will provide easy access which will help to solve difficult problems.We believe on pro-active approach of the market and keep an eye on the recent developments in the R&D and next-generation technologies.

Read Free Sample Report @ http://www.mrsresearchgroup.com/report/94219#request-sample

Highlights of the report:

A complete backdrop analysis, which includes an assessment of the parent market
Important changes in market dynamics
Market segmentation up to the second or third level
Historical, current, and projected size of the market from the standpoint of both value and volume
Reporting and evaluation of recent industry developments
Market shares and strategies of key players
Emerging niche segments and regional markets

Global Medical Pillows Market 2016 focuses on sales, market share and growth rate of Medical Pillows Market in each application, can be divided into

Application 1
Application 2
Application 3

The report comprises in-depth information of definition, application, types, drivers, and various other aspects. It includes internal and external factors responsible for the growth of the market. Our research regarding the Global Medical Pillows Market 2016. We use varied tools and techniques in order to assemble data such as value chain analysis, company profiles, and product specifications.

Browse Latest Research Report on machinery-and-equipmentst @ http://www.mrsresearchgroup.com/category/machinery-and-equipments.html

MRS Research Group provides a range of marketing and business research solutions designed for our client“s specific needs based on our expert resources. The business scopes of Prof Research cover more than 30 industries including energy, new materials, transportation, daily consumer goods, chemicals, etc. We provide our clients with one-stop solution for all the research requirements.

Kontakt
MRS Research Group
Leo Mesi
3422 SW 15 Street,Suit # 8138 Flori
33442 Deerfield Beach,Florida
13863103803
lmesi6589@gmail.com
http://www.mrsresearchgroup.com

Medicine Wellness Health

Prostate cancer: Identifying and destroying the tumour through nuclear medicine therapy

(Vienna, December 13, 2016) Prostate cancer patients who are resistant to hormone treatment used to have a poor prognosis. Until recently, the diagnostic and therapeutic possibilities had been limited, but now innovative developments in nuclear medicine imaging and therapy open up promising pathways. Novel substances used with PET/CT (positron-emission tomography combined with computed tomography) not only allow for better diagnosis but also offer treatment options where other therapies have failed. „This offers a glimpse of hope to patients who suffer from this particularly severe form of prostate cancer,“ says EANM expert Prof. Markus Luster.
Prostate cancer is the second most frequently diagnosed cancer in men and causes around 90.000 deaths per year in Europe. Up to every second patient who has his prostate surgically removed or has undergone radiation therapy suffers from relapse. In severe cases the level of testosterone upon which the tumour is dependent to a large extent has to be reduced drastically in order to fight the disease. This is usually done by hormone therapy. However, a considerable number of patients are or will become resistant to this kind of treatment (so called castration-resistant prostate cancer / CRPC). This means that in spite of therapy the tumour has not been destroyed definitively and in many cases is now affecting the lymph nodes or has even extended to the stage of often painful bone metastases. Prognosis of patients who progress to this stage is poor.

A common means to detect prostate cancer and assess the stage of the disease is the measurement of the level of prostate-specific antigen (PSA), which serves as a biomarker for the presence of cancer cells. However, in patients whose testosterone production has been suppressed medically PSA levels are often too low to be measured. This includes CRPC patients in whom this therapy has failed to eradicate or halt the tumour. Moreover, PSA measurement provides no information about the sites and the extent of the recurrent cancer. However, newly developed nuclear medicine methods have opened up promising diagnostic avenues that might more sensitively and accurately enlighten both patient and physician about the location and extent of disease. At the same time, this new approach also provides new therapeutic modalities which can improve the still poor prognosis of CRPC-patients in the future. The leading part is played by a protein called Prostate-Specific Membrane Antigen (PSMA). It is found abundantly on the surface of prostate cancer cells and its number appears to be increasing with the aggressiveness of the disease. This makes PSMA an ideal target for detecting cancer cells by nuclear imaging. The essential means to achieve this is the Ga-68-PSMA-ligand, a substrate that binds to PSMA – comparable to a key that fits into its lock – which is labelled with the radionuclide Gallium 68. This tracer has already been used successfully in a large number of PET/CT examinations: After the patient has been injected with Ga-68-PSMA-ligand the tracer is taken up by the cancer cells which are made visible for the examining physicians by the radiation. „The substance has proven to be highly sensitive and reliable in detecting carcinoma in lymph nodes as well as metastases in other body regions. Over the past decade or so other substances such as choline have been evaluated and applied but in terms of accuracy and diagnostic outcome Ga-68-PSMA is now state of the art,“ says Prof. Markus Luster.

As he points out PSMA is not only useful for diagnostic but also for treatment purposes: The PSMA-ligand can be labelled with another radionuclide called Lutetium-177 that is able to destroy the cancer cell from inside through radiation. „Several tests have demonstrated that Lu-177-PSMA-therapy can reduce tumour mass and alleviate pain. Patients who have no other treatment options left and whose cancer cells have been shown to take up PSMA-ligands are very likely to benefit from the diagnostic and therapeutic potential of PSMA imaging and therapy,“ says Prof. Markus Luster.
Visit EANM on Facebook
What is nuclear medicine?

Presseagentur für Medizinthemen

Kontakt
impressum health & science communication
Frank von Spee
Hohe Brücke 1
20459 Hamburg
040 31786410
vonspee@impressum.de
http://www.impressum.de

Medicine Wellness Health

Product innovation: Poltava-Bischofite

Crystalline mineral concentrate as a bath additive with magnesium chloride, juniper oil, spruce oil and eucalyptus oil

Product innovation: Poltava-Bischofite

Poltava-Bischofite

Bischofite is a rarely occurring mineral. It is composed as follows: MgCl2 – 6H2O and is therefore chemically a water-containing magnesium chloride.
There are only a few proven Bischofite discovery sites in the world. Even more rare are the „pure“ Bischofite existence with a mineral content of more than 93%. Among these rare occurrences is the mine near the town of Poltava in Ukraine. The occurrence in Poltava is with 2.5 km the deepest in the world and is therefore also the oldest. Probably this fact makes the Poltava-Bischofite particularly valuable and gives it distinct healing and health-promoting properties. The exploration of the Bischofite from the Poltava mine began in the nineties, shortly after the discovery of the mineral here.
During the years 1993-1996 in the Medical Academy of Dnepropetrovsk the effectiveness of the mineral was not only proved in the treatment of the movement apparatus. Its positive effect was also found in the cardiological diseases (coronary heart disease, hypertension, tachyarrhythmias). In addition, the antibacterial and immunostimulatory properties of the mineral have been proven.
Effective use of bischofite electrophoresis has been demonstrated in the treatment of bile tracts disorders in the Poltava Medical Institute (1998-2002) and in the rehabilitation of liquidators of the Chernobyl disaster (1996-2003).
The Research Institute for Hygiene and Medical Ecology in Kiev (2002-2004) confirmed the safety of the use of bischofite on humans.
Bischofite has already established itself very well in the treatment of diseases of the movement apparatus and the peripheral nervous system.
Waterbaths with the feeding of Bischofite are helpful with: arthrosis, arthritis, osteochondrosis, sequelae after injuries, contractures, neuroses, neuritis, lumbago (low back pain), neuralgia, sciatica, vegetative dystonia, metabolic disorder, worsening of general wellbeing, reduction of performance, stress, sleep disorder, complex health-promoting measures.
More information: https://sivash.de/en/Bischofite

Company ALNOVA imports and distributes natural wellness and health products in the EU based on the unique peloid from the salt lake Sivash. This is a salt-, magnesium- and sulphide-containing sea silt.
The peloid works very well with chronic diseases of the bones, joints and spine as well as with skin diseases such as psoriasis, neurodermatitis and acne. The sea silt is distributed under the name SIVASH-healing sea mud. In addition to the healing sea mud itself, there are a number of body care products on a healing sea mud basis. Besides, the special pink sea salt also belongs to the company’s product range. Both the sea silt and the salt are formed under the pink brine, which is rich in the microalgae Dunaliella Salina with high beta-carotene content. This fact makes the SIVASH-healing sea mud and sea salt particularly valuable and unique.

Kontakt
ALNOVA
Alexey Layer
Esslinger Str. 61
76228 Karlsruhe
+49(0)721-4539839
049(0)721-4538149
info@sivash.de
https://sivash.de

Medicine Wellness Health

Groupanalycis of Triplettsequences

Since its detection, the HIV viral disease (AIDS) is causally resistant to anytherapy.A cure seems to be possible at symmtomatical level, as it is with other viral diseases. Hence in an essay does examine the underlying structure of the HIV virus RNA sequence using the model of Cohorts of Barcelona, and will provide the finding that, in priciple, base pair tripletts may be considered as spatial linguistic entities or conditions, similar to the Kleinian group in mathematics, and therefore a RNA/DNA.thread in this way basically depicts a conglomerate of symmetries (conditions). This uncloses a new theoretical basis of a syntactically symmertric interpretaton as well as an etiological therapy for instance a structurally inverted construct used as antiviral genetic structure.

Labor Dr .Hübers in Havixbeck NRW

Kontakt
Labor Dr.Hübers
Reinhard Dr.Hübers
An der Feuerwache 2
48329 Havixbeck
016093521502
r.huebers@gmx.de
http://Lenti23.jimdo.com

Medicine Wellness Health

Automated Suturing Devices Market to be Worth US$ 471 Mn by 2015

Global automated suturing devices market is estimated to account for US$ 471.0 Mn by the end of 2015, mainly driven by rising number of minimally invasive surgical procedures.

Automated Suturing Devices Market to be Worth US$ 471 Mn by 2015

Automated Suturing Devices Market

Future Market Insights (FMI), in its latest report titled, „Automated Suturing Devices Market: Global Industry Analysis and Opportunity Assessment 2015-2025“, forecasts the global automated suturing devices market revenue to expand at a CAGR of 5.3% during the forecast period (2015-2025). Global automated suturing devices market is estimated to account for US$ 471.0 Mn by the end of 2015, mainly driven by rising number of minimally invasive surgical procedures.

Use of automated suturing devices in minimal invasive surgeries, open surgical procedures and major trauma cases that require surgery is expected to drive the market during the forecast period. Preference for automated suturing devices over conventional suturing devices during laparoscopic surgeries is a key reason for growth. Further, the device is also preferred by procurement teams at hospitals as it labelled under „green products“, resulting in considerably less impact on the environment as compared to plastic single-use disposable suturing devices.Rise in geriatric population is a macro factor that“s driving demand for automated suturing devices.

High cost along with negative perception about certain automated suturing devices due tosome FDA-approved devices facing criticism regarding performance can impede the growth of the market.

Request Report Sample with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-579

The report analyses the global automated suturing devices market in terms of market value (US$ Mn) and market volume (units) by product type, region, end-user and application. The report also offers information regarding market dynamics, regulatory compliances, competitive landscape, current trends, market estimations and forecast.

Region-wise, North America is expected to account for maximum volume share in the global market by 2015and this is expected to double over the forecast period. Western Europe is the second-most lucrative market for automated suturing devices companies. The market revenue in this region is projected to witness a healthy CAGR of 5.6% during the forecast period.

Browse the full „Automated Suturing Devices Market: Global Industry Analysis and Opportunity Assessment 2015 – 2025“ market research report at http://www.futuremarketinsights.com/reports/automated-suturing-devices-market

Among product types, disposable automated suturing devices segment is expected to dominate the global automated suturing devices market,followed by the reusable automated suturing devices segment. Increasing prevalence of obesity is expected to boost overall demand for disposable automated suturing devices at a comparatively higher pace.

On the basis of application, automated suturing devices market is segmented into minimally invasive surgeries, open surgeries and trauma cases. Minimally invasive surgeries segment is expected to dominate the overall automated suturing devices market by the end of forecast period. The segment revenue is projected to register fastest growth rate over the forecast period. Open surgeries is projected to be the second fastest growing segment in terms of revenue. Increasing adoption of automated suturing devices among surgeons is fuelling growth of the minimally invasive surgeries segment.

Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-579

On the basis of end user, global automated suturing devices market has been segmented into hospitals, clinics and ambulatory surgical centers. Hospitals segment is expected to register fastest CAGR in terms of revenue over the forecast period.

Key players profiled in FMI“s market study include Medtronic Plc., Inc., Apollo Endosurgery, LSI Solutions, Inc., Boston Scientific, C. R. Bard, SuturTek Inc. and EndoEvolution, LLC.

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI“s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Kontakt
Future Market Insights
Abhishek Budholiya
616 Corporate Way, Suite 2-9018, Valley Cottage NY
10989 New York
+442076928790
abhishek.b@futuremarketinsights.com
http://www.futuremarketinsights.com/

Medicine Wellness Health

Bone Growth Stimulators Market to Account for US$ 1,097.6 Mn by 2016

An external bone growth stimulator is prescribed for use for two to nine hours every day for a period of around three to nine months.

Bone Growth Stimulators Market to Account for US$ 1,097.6 Mn by 2016

Bone Growth Stimulators

According to the latest market report published by Future Market Insights titled, „Bone Growth Stimulators Market: Global Industry Analysis and Opportunity Assessment, 2015-2025“, the bone growth stimulators market is anticipated to expand at a CAGR of 9.5% during the forecast period.

Bone growth stimulators are used in cases of delay or failure of fracture healing as they enhance the bone healing process without the sensation of electrical shocks or currents or vibrations when worn by the user. An internal bone growth stimulator or invasive bone growth stimulator is implanted on the fusion site of the bone and it delivers small electrical currents. The internal bone growth stimulator is removed from the body after 6-12 months. External bone growth stimulator or non-invasive bone growth stimulators are externally worn portable devices and do not require surgical implantation. An external bone growth stimulator is prescribed for use for two to nine hours every day for a period of around three to nine months.

Economic factors such as improvement in service sector, increase in personal income, and increase in per capita healthcare expenditure are expected to drive market growth globally. Captivating product features, expanding application in the sports medicine industry, high disability cost payments, among others, are fuelling growth of the global bone growth stimulators market. However, various factors such as availability of alternative therapies, uncertainty about efficacy, device-related issues and competition from bone grafts restraint growth of the bone growth stimulators market.

Request Report Sample with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-828

By product, the global bone growth stimulators market is segmented into invasive bone growth stimulators, non-invasive bone growth stimulators and ultrasound bone growth stimulators. The non-invasive bone growth stimulators product segment-which comprises capacitive coupling devices, combined magnetic field devices and pulsed ultrasound magnetic field devices-accounts for the highest market share currently and is expected to remain the leading segment in terms of value during the forecast period. In terms of application segmentation, trauma injury and fractures segment is expected to expand at the highest CAGR in terms of value and volume over the forecast period as compared to other applications. Hospitals end user segment, though projected to account for the highest share in market, is expected to expand at an average CAGR in terms of value and volume over the forecast period. Orthopedic clinics and home care end user segments are expected to represent significant market attractiveness indices over the forecast period.

Browse the full „Bone Growth Stimulators Market: Global Industry Analysis and Opportunity Assessment, 2015-2025“ market research report at http://www.futuremarketinsights.com/reports/bone-growth-stimulators-market

By region, North America is expected to remain the market leader in the bone growth stimulators market mainly due to consumer awareness about chronic pain related to bone fracture and injury and subsequent disability costs. Western Europe is the second-largest contributor to the global market in terms of value and volume owing to availability of public health systems and subsidies coupled with reliance of patients on the Internet to research about new technologies, such as bone growth stimulators. MEA is projected to expand at a significant pace mainly due to large (particularly expatriate) population, improvements in life expectancy and decline in mortality rates, combined with increased budgetary spend on healthcare, resulting in a major shift and boost in growth of the bone growth stimulators market in the MEA countries. The MEA bone growth stimulators market is still untapped, so companies have substantial growth opportunities in this region.

Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-828

Key market players covered in this report are DJO LLC, Orthofix International N.V., Zimmer Biomet Holdings Inc., Elizur, Bioventus LLC., Ossatec Benelux BV, Verve Consulting Inc. and IGEA S.p.A. Major players in the bone growth stimulators market are focusing on enhancing their global and regional presence through strategic mergers & acquisitions and operational expansion.

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI“s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Kontakt
Future Market Insights
Abhishek Budholiya
616 Corporate Way, Suite 2-9018, Valley Cottage NY
10989 New York
+442076928790
abhishek.b@futuremarketinsights.com
http://www.futuremarketinsights.com/

Medicine Wellness Health

Breast Pumps Market Will hit at a CAGR of 5% from 2016 to 2026

Breast pumps haven“t undergone the same level of innovation as other medical devices, prompting the „Make the Breast Pump Not Suck“ hackathon at MIT Media Lab in 2014.

Breast Pumps Market Will hit at a CAGR of 5% from 2016 to 2026

Breast Pumps Market

„Breast Pumps Market: Global Industry Analysis and Opportunity Assessment, 2016-2026“, a new report by research and consulting firm, Future Market Insights (FMI) forecasts the global breast pumps market to increase at 5% CAGR through 2026 and surpass US$ 2 Bn in revenues. The report offers 10-year forecast and analysis on the basis of product, technology, application, and region. Key companies profiled in the report include Koninklijke Philips N.V, Pigeon Corporation, Jarden Corporation, Goodbaby International Holdings Ltd., Medela Inc., Ameda Inc., Hygeia Medical Group II, Bailey Medical, Handi-Craft Company, Mayborn Group Limited, and Linco Baby Merchandise Works Co., Ltd.

Breast pumps haven“t undergone the same level of innovation as other medical devices, prompting the „Make the Breast Pump Not Suck“ hackathon at MIT Media Lab in 2014. The hackathon received massive media coverage, bringing daunting challenges associated with breast pumps to the limelight. While breast pumps have enabled women to maintain their milk production and provide nutritious feed to their babies in their absence, using the pumps has been a complicated affair. High cost, deafening loud motors, and difficulty in cleaning numerous parts has forced many women to wean.

Request Report Sample with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-967

The winners of M.I.T“s hackathon presented interesting, futuristic ideas that could change the breast pumps landscape for the better. Hands-free, discrete, and easy to clean – the winning products incorporated features that women have been yearning for a long time. Manufacturers looking to gain a competitive edge need to work on including these features in their offerings.

Global Breast Pumps Market: Challenges and Opportunities

Global demand for breast pumps will continue to grow, as the percentage of working moms increases, especially in developing countries. Breast pumps“ use as a life-saving device for infants who cannot feed directly from the breast is also expected to contribute to global demand.

Browse the full „Breast Pumps Market: Global Industry Analysis and Opportunity Assessment, 2016-2026“ market research report at http://www.futuremarketinsights.com/reports/breast-pumps-market

According to FMI“s report, double electric breast pumps are witnessing higher demand than single electric- and manual- breast pumps. Ease of use and faster expression of milk are the key factors driving demand for double electric breast pumps. Overall, demand for breast pumps is higher from individual consumer (s) vis-à-vis hospitals.

High Demand Expected in Emerging Economies

North America and Western Europe are the two largest markets for breast pumps globally, with the former accounting for nearly 35% revenue share of the market in 2015. Developing economies promise myriad growth opportunities to manufactures, as the breast pumps market in these region is still in its infancy. According to FMI“s report, the Asia Pacific excluding Japan (APEJ) breast pumps market is anticipated to witness a CAGR of 7.1% CAGR, whereas the Eastern Europe breast pumps market is expected to increase at 4.5% CAGR. Russia is the most lucrative market for breast pumps in Eastern Europe, and is projected to increase at 4.6% CAGR during the forecast period.

Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-967

Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI“s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Kontakt
Future Market Insights
Abhishek Budholiya
616 Corporate Way, Suite 2-9018, Valley Cottage NY
10989 New York
+442076928790
abhishek.b@futuremarketinsights.com
http://www.futuremarketinsights.com/